Air and Thermally Stable Fluoride Bridged Rare-Earth Clusters Showing Intense Photoluminescence and Potential LED Application

© 2024 Wiley‐VCH GmbH.

Détails bibliographiques
Publié dans:Advanced materials (Deerfield Beach, Fla.). - 1998. - 36(2024), 47 vom: 08. Nov., Seite e2406882
Auteur principal: He, Jian-Yue (Auteur)
Autres auteurs: Wang, Yu, Chen, Xi, Chen, Wei-Peng, Zhou, Guijiang, Zheng, Yan-Zhen
Format: Article en ligne
Langue:English
Publié: 2024
Accès à la collection:Advanced materials (Deerfield Beach, Fla.)
Sujets:Journal Article clusters light‐emitting diodes luminescent phosphors rare‐earth
Description
Résumé:© 2024 Wiley‐VCH GmbH.
Fluoride based lattice is attractive for reducing phonon-induced quenching in rare-earth (RE) based luminescent materials. However, due to the strong affinity between RE and oxygen, the synthesis of fluoride-based complexes has to be protected under anhydrous conditions, and many known fluoride bridged RE clusters are unstable in air. Here, by using the "mixed-ligand" strategy a family of fluoride bridged RE clusters is synthesized, namely RE16(μ4-F)6(μ3-F)12(tBuCOO)18[N(CH2CH2O)3]4 (RE = Eu, EuFC-16; RE = Tb, TbFC-16), which are highly stable in air and decomposed thermally only when heating above 435 °C. Moreover, both clusters exhibit high photoluminescence quantum yields (PLQYEuFC-16 = 87.7%, PLQYTbFC-16 = 99.0%). Upon warming, EuFC-16 and TbFC-16 display excellent structural, thermal, and chroma stability. Thus, EuFC-16 and TbFC-16 have the potential to be used in light-emitting diode (LED) devices, offering many advantages over commercial phosphors. First, both clusters are soluble in UV-curable resin at any mixing rate, and the emission colors can be tuned from magenta, turquoise, willow green, and ivory to pure white if mixing blue phosphor BAM:Eu2+. Second, the clusters are hydrophobic, and the LEDs work well after soaking in water, indicating a good quality for outdoor lighting
Description:Date Revised 25.11.2024
published: Print-Electronic
Citation Status PubMed-not-MEDLINE
ISSN:1521-4095
DOI:10.1002/adma.202406882